MAPT and tauopathy: Tau-PET allows for the exclusion of tauopathies in the differential diagnosis of neurodegenerative Parkinson syndromes as well as for the assessment of tau copathology in PD-associated dementia (Brendel et al. 2020; Tang et al. 2023).